Modest alcohol consumption has an inverse association with liver fat content

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2552-2556

  Gunji, Toshiaki ^a   Sato, Hajime ^b   Iijima, Kimiko ^a   Fujibayashi, Kazutoshi ^a   Okumura, Mitsue ^a   Sasabe, Noriko ^a   Matsuhashi, Nobuyuki ^a  

^a Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Alcohol; CT; Fatty liver; Liver fat content

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FAT CONTENT; FATTY LIVER; HUMAN; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ADULT; ALCOHOL DRINKING; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FATTY LIVER; HUMANS; INTRA-ABDOMINAL FAT; JAPAN; LINEAR MODELS; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SUBCUTANEOUS FAT, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84872095418     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12175     Document Type: Article

References (25)

1. Browning JD, Szczepaniak LS, Dobbins R, et al.: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40:1387-1395.
2. Becker U, Grønbaek M, Johansen D, Sørensen TI: Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002; 35:868-875.
3. Suzuki A, Angulo P, Sauver J, et al.: Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 2007; 102:1912-1919.
4. Gunji T, Matsuhashi N, Sato H, et al.: Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 2009; 104:2189-2195.
5. Yamada T, Fukatsu M, Suzuki S, et al.: Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup. Dig Dis Sci 2010; 55:176-182.
6. Strauss S, Gavish E, Gottlieb P, Katsnelson L: Inter-observer and intra-observer variability in the sonographic assessment of fatty liver. AJR 2007; 189:W320-323.
7. Palmentieri B, de Sio I, La Mura V, et al.: The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006; 38:485-489.
8. Kodama Y, Ng CS, Wu TT et al.: Comparison of CT methods for determining the fat content of the liver. AJR 2007; 188:1307-1312.
9. Limanond P, Raman SS, Lassman C, et al.: Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230:276-20.
10. Borkan GA, Gerzof SG, Robbins AH, et al.: Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982; 36:172-177.
11. Brinkman GL, Coates EO Jr: The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis 1963; 87:684-693.
12. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW: The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 2004; 127:1798-1808.
13. Lu Y, Zhuge J, Wang X, Bai J, Cederbaum AI: Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 2008; 47:1483-1494.
14. Zhou Z, Wang L, Song Z, et al.: A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol 2003; 163:1137-1146.
15. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al.: Non-alcoholic steatohepatitis: association of insulin resistance and mltochondrial abnormalities. Gastroenterology 2001; 120:1183-1192.
16. Fraser A, Ebrahim S, Smith GD, Lawlor DA: A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. Hepatology 2007; 46:158-165.
17. Oh SY, Cho YK, Kang MS, et al.: The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006; 55:1604-1609.
18. Baur JA, Pearson KJ, Price NL, et al.: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444:337-342.
19. Schulze MB, Hoffmann K, Manson JE, et al.: Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am Clin Nutr 2005; 82:675-684.
20. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD: Splanchnic lipolysis in human obesity. J Clin Invest 2004; 113:1582-1588.
21. Naveau S, Giraud V, Borotto E, AubertA, Capron F, Chaput JC: Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25:108-111.
22. Weiss R, Dziura J, Burgert TS, et al.: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350:2362-2374.
23. Palmer M, Schaffner F: Effect of weight reduction on hepatic abnormalities In overweight patients. Gastroenterology 1990; 99:1408-1413.
24. Clark JM, Brancati FL, Diehl AM: The prevalence and etiology of elevated aminotransferase levels in the United States. Am Gastroenterol 2003; 98:960-967.
25. Wang Y, Seitz BK, Wang XD: Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcohol Clin Exp Res 2010; 34:567-573.